MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects

One of the most challenging tasks of the cancer research is the enhancement of the amount of the chemotherapeutic agent that can reach the target site. To achieve this goal, nanovectors capable of encapsulating the drug and releasing it following a specific stimulus have been developed. In light of...

Full description

Bibliographic Details
Main Authors: Deyssy Patrucco, Enzo Terreno
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Physics
Subjects:
MRI
Online Access:https://www.frontiersin.org/article/10.3389/fphy.2020.00325/full
id doaj-598230969c0640b3b0e5429cad61a765
record_format Article
spelling doaj-598230969c0640b3b0e5429cad61a7652020-11-25T03:40:17ZengFrontiers Media S.A.Frontiers in Physics2296-424X2020-08-01810.3389/fphy.2020.00325555561MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced EffectsDeyssy PatruccoEnzo TerrenoOne of the most challenging tasks of the cancer research is the enhancement of the amount of the chemotherapeutic agent that can reach the target site. To achieve this goal, nanovectors capable of encapsulating the drug and releasing it following a specific stimulus have been developed. In light of this, a key point is the necessity to monitor the effective drug release through a safe and highly performing imaging technology such as Magnetic Resonance Imaging (MRI). Liposomes are highly biocompatible nanovesicles that consist of bilayered phospholipid-based membrane encompassing an aqueous core. Almost 20 drug-loaded liposomes are currently approved for clinical use in USA and EU countries. If a liposomal nanomedicine is loaded with an MRI agent whose contrast is sensitive to the microenvironment and with a release kinetics similar to the co-transported drug, the system can act as an imaging reporter of drug release. This Perspective will offer a critical and brief overview of using MRI not only to verify and monitor the release process but also as a valuable tool to predict the therapeutic outcome. In particular, it will be presented representatives preclinical studies illustrating the in vivo potential of MRI-guided drug release protocols triggered by thermal and mechanical ultrasound-induced effects. Considering the therapeutic advantages of this approach, the possible benefits in reducing the side effects and the good results reported at preclinical level, there is a reasonable hope that the near future could witness the entrance in clinical routine of MRI-guided procedures supporting ultrasound-induced drug release protocols.https://www.frontiersin.org/article/10.3389/fphy.2020.00325/fullMRIultrasoundliposomesdrug releasenanomedicine
collection DOAJ
language English
format Article
sources DOAJ
author Deyssy Patrucco
Enzo Terreno
spellingShingle Deyssy Patrucco
Enzo Terreno
MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
Frontiers in Physics
MRI
ultrasound
liposomes
drug release
nanomedicine
author_facet Deyssy Patrucco
Enzo Terreno
author_sort Deyssy Patrucco
title MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
title_short MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
title_full MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
title_fullStr MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
title_full_unstemmed MR-Guided Drug Release From Liposomes Triggered by Thermal and Mechanical Ultrasound-Induced Effects
title_sort mr-guided drug release from liposomes triggered by thermal and mechanical ultrasound-induced effects
publisher Frontiers Media S.A.
series Frontiers in Physics
issn 2296-424X
publishDate 2020-08-01
description One of the most challenging tasks of the cancer research is the enhancement of the amount of the chemotherapeutic agent that can reach the target site. To achieve this goal, nanovectors capable of encapsulating the drug and releasing it following a specific stimulus have been developed. In light of this, a key point is the necessity to monitor the effective drug release through a safe and highly performing imaging technology such as Magnetic Resonance Imaging (MRI). Liposomes are highly biocompatible nanovesicles that consist of bilayered phospholipid-based membrane encompassing an aqueous core. Almost 20 drug-loaded liposomes are currently approved for clinical use in USA and EU countries. If a liposomal nanomedicine is loaded with an MRI agent whose contrast is sensitive to the microenvironment and with a release kinetics similar to the co-transported drug, the system can act as an imaging reporter of drug release. This Perspective will offer a critical and brief overview of using MRI not only to verify and monitor the release process but also as a valuable tool to predict the therapeutic outcome. In particular, it will be presented representatives preclinical studies illustrating the in vivo potential of MRI-guided drug release protocols triggered by thermal and mechanical ultrasound-induced effects. Considering the therapeutic advantages of this approach, the possible benefits in reducing the side effects and the good results reported at preclinical level, there is a reasonable hope that the near future could witness the entrance in clinical routine of MRI-guided procedures supporting ultrasound-induced drug release protocols.
topic MRI
ultrasound
liposomes
drug release
nanomedicine
url https://www.frontiersin.org/article/10.3389/fphy.2020.00325/full
work_keys_str_mv AT deyssypatrucco mrguideddrugreleasefromliposomestriggeredbythermalandmechanicalultrasoundinducedeffects
AT enzoterreno mrguideddrugreleasefromliposomestriggeredbythermalandmechanicalultrasoundinducedeffects
_version_ 1724535030117564416